GET THE APP

Identification of Hepatoprotective Peptide Based Leads against Multiple Receptor Targets using Docking Strategy. | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.

Abstract

Identification of Hepatoprotective Peptide Based Leads against Multiple Receptor Targets using Docking Strategy.

Author(s): Nagarajan K, Shikha, Grover P, Ghai R

Peptides are well known for bio-friendly properties are being designed as the hepatoprotective agents in this research study. After the analysis of all the results using Swiss Dock against different targets, it was observed that particular peptides (Arg-Lys-Pro, Lys-Glu-Leu) were identified as a best lead against the asialoglycoprotein receptor 1, TLR-2 and nulear receptor subfamily 5 group a member 2. Later, when these compounds were subjected to docking against the P-glycoprotein, it was found that Arg-Lys-Pro and Lys-Glu-Leu were having fullfitness energy as -175561.75 kJ/mol (lesser binding energy) and -155255.80 kJ/mol (lesser binding energy). In similarity, the same tripeptides (Arg-Lys-Pro, Lys-Glu-Leu) which are effective against and receptor targets are having very less binding energy with P-gp, indicating P-gp efflux mechanism for these drugs is low and hence they surely may have enhanced bioavailability even if tested in various phases of clinical trials. Hence, these peptides are discovered as one of the leads against their respective target sites, which can be utilised in the liver ailments and further needs investigation in pre-clinical & clinical studies as suitable hepatoprotective agents in near future.


Full-Text PDF

Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 15261

Der Pharma Chemica received 15261 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry